Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06896903 · ClinicalTrials.gov registry record · NA

Analysis of Coronary Reactivity Testing With and Without Intracoronary Nitrate Testing

A NA study of ANOCA - Angina With Non-obstructive Coronary Arteries and INOCA (Ischemia With Non Obstructive Coronary Artery Disease), sponsored by Baylor Research Institute.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06896903 is a NA study of ANOCA - Angina With Non-obstructive Coronary Arteries and INOCA (Ischemia With Non Obstructive Coronary Artery Disease) that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06896903, a NA study of ANOCA - Angina With Non-obstructive Coronary Arteries and INOCA (Ischemia With Non Obstructive Coronary Artery Disease), is actively recruiting participants, sponsored by Baylor Research Institute.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This single-arm, multi-center, prospective study will assess the coronary flow reserve (CFR), index of microcirculatory resistance (IMR), and determinants thereof (transit time, Pa, Pd) in patients before and after intracoronary nitroglycerine.

Interventions

  • DIAGNOSTIC_TEST Coronary reactivity testing with and without nitrates

Study Locations (1)

Texas

  • Baylor Scott & White The Heart Hospital - Plano - Plano

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-05-21
Est. Completion 2026-06-01
Phase NA

Sponsor

Baylor Research Institute

180 total trials

What the Registry Record Tells You About NCT06896903

The ClinicalTrials.gov registry entry for NCT06896903 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with ANOCA - Angina With Non-obstructive Coronary Arteries appearing as the primary indexed condition, and to 1 intervention - of which Coronary reactivity testing with and without nitrates is the first listed.

NCT06896903 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06896903 about?

NCT06896903 is a clinical study titled "Analysis of Coronary Reactivity Testing With and Without Intracoronary Nitrate Testing". This single-arm, multi-center, prospective study will assess the coronary flow reserve (CFR), index of microcirculatory resistance (IMR), and determinants thereof (transit time, Pa, Pd) in patients before and after intracoronary nitroglycerine.

What is the current status of trial NCT06896903?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-05-21. Estimated completion is 2026-06-01.

What conditions does trial NCT06896903 study?

This clinical trial studies the following conditions: ANOCA - Angina With Non-obstructive Coronary Arteries, INOCA (Ischemia With Non Obstructive Coronary Artery Disease).

What interventions are being tested in trial NCT06896903?

The interventions under investigation include: Coronary reactivity testing with and without nitrates (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06896903?

This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06896903 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.